Tag: Biocon
Biocon Biologics Receives USFDA Approval for Insulin Aspart Biosimilar ‘Kirsty’
Biocon Biologics, India’s pride in global biotech, has just scored a major win. The US Food and Drug…
Biocon’s Vevzuo and Evfraxy Approved in UK for Bone Disease Treatment
Biocon has made a bold move. Its Denosumab biosimilars—Vevzuo and Evfraxy—have just been approved by the UK MHRA.…
Biocon Gets EU Greenlight, Delivers Breakthrough Denosumab Biosimilars
Biocon just scored a major win in Europe—this time for your bones. The biotech giant got the green…
Biocon Eyes Early Lead in Canada’s Generic Wegovy, Ozempic Market
Biocon is getting ready for a big move in the weight-loss drug world. The Bengaluru-based company is planning…
Biocon Abandons China Plan for Weight-Loss Drugs; 15+ Local Rivals Crowd Market
India’s Biocon has decided not to launch its versions of Novo Nordisk’s weight-loss blockbusters Ozempic and Wegovy in…
HSBC Keeps ‘Buy’ Rating on Biocon After Company Raises ₹4,500 Crore via QIP
Pharma player Biocon is back in the spotlight—and this time with serious backing. After the launch of its…
Biocon’s Latest Win: Cheaper Diabetes Treatment Option for India
Bangalore-based Biocon has secured approval from the Central Drugs Standard Control Organisation (CDSCO) for Liraglutide, a crucial diabetes…
Biocon Poised to Dominate Diabetes-Obesity Space, Says Kiran Mazumdar-Shaw
Biocon is gearing up to become a dominant player in the diabetes and obesity drug market. This comes…
Biocon’s Q4 Results: Profit Jumps 154% YoY to ₹344 Crore on Strong Performance
Biocon's profit for the fourth quarter (Q4) of the financial year 2025 has increased by 154% compared to…
Biocon Sees 3.10% Jump After Securing U.S. Deal for Yesafili Biosimilar—Is This a Game Changer?
Biocon, a global leader in biopharmaceuticals, is making waves in the ophthalmology field with the launch of Yesafili,…
Biocon FDA Approval JOBEVNE Biosimilar Could Rewrite Cancer Care Costs
Biocon FDA Approval for JOBEVNE Biosimilar Marks a Big Win in Cancer Care Biocon Biologics has received U.S.…
Great News! Biocon’s new blood pressure injection gets US FDA approval Know how this could help patients!
Biocon Ltd., a well-known biopharmaceutical company, has received approval from the US FDA for its norepinephrine bitartrate injection.…